Prognostic Value And Clinical Impact Of EBV And PDL1 Expression In Classical Hodgkin Lymphoma. Journal of Pharmaceutical Negative Results, [S. l.], p. 3461–3472, 2023. DOI: 10.47750/pnr.2023.14.02.406. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/8451.. Acesso em: 9 jun. 2026.